X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (59) 59
index medicus (48) 48
male (48) 48
female (47) 47
middle aged (47) 47
aged (45) 45
life sciences (44) 44
hematology (43) 43
adult (35) 35
cancer (33) 33
aged, 80 and over (31) 31
prognosis (27) 27
treatment outcome (27) 27
oncology (20) 20
retrospective studies (20) 20
chemotherapy (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
lymphoma (18) 18
survival analysis (16) 16
[ sdv.can ] life sciences [q-bio]/cancer (15) 15
[sdv.can]life sciences [q-bio]/cancer (15) 15
lymphomas (15) 15
rituximab (15) 15
leukemia (13) 13
cyclophosphamide (12) 12
survival (12) 12
follow-up studies (11) 11
leukemia, lymphocytic, chronic, b-cell - drug therapy (11) 11
patients (11) 11
antineoplastic agents - therapeutic use (10) 10
biopsy (10) 10
human health and pathology (10) 10
therapy (10) 10
care and treatment (9) 9
diagnosis (9) 9
neoplasm staging (9) 9
non-hodgkins-lymphoma (9) 9
survival rate (9) 9
[sdv]life sciences [q-bio] (8) 8
b-cell lymphoma (8) 8
fluorodeoxyglucose f18 (8) 8
hemic and lymphatic diseases (8) 8
[sdv.mhep.hem]life sciences [q-bio]/human health and pathology/hematology (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
chronic lymphatic leukemia (7) 7
disease progression (7) 7
disease-free survival (7) 7
leukemia, lymphocytic, chronic, b-cell - mortality (7) 7
lymphoma, large b-cell, diffuse - drug therapy (7) 7
recurrence (7) 7
research (7) 7
risk factors (7) 7
trial (7) 7
chronic lymphocytic leukemia (6) 6
follow-up (6) 6
international workshop (6) 6
medical research (6) 6
positron-emission tomography - methods (6) 6
transplantation (6) 6
[ sdv ] life sciences [q-bio] (5) 5
aggressive lymphoma (5) 5
analysis (5) 5
angioimmunoblastic t-cell lymphoma (5) 5
chlorambucil (5) 5
cyclophosphamide - administration & dosage (5) 5
diffuse large b-cell lymphoma (5) 5
drug administration schedule (5) 5
expression (5) 5
france - epidemiology (5) 5
immune system diseases (5) 5
immunohistochemistry (5) 5
lymphoma, t-cell, peripheral - pathology (5) 5
medical prognosis (5) 5
medicine, experimental (5) 5
oncology, experimental (5) 5
open-label (5) 5
pathology (5) 5
prospective studies (5) 5
pyrazoles - therapeutic use (5) 5
pyrimidines - therapeutic use (5) 5
risk (5) 5
rituximab - administration & dosage (5) 5
stem cell transplantation (5) 5
young adult (5) 5
[ sdv.mhep.hem ] life sciences [q-bio]/human health and pathology/hematology (4) 4
abridged index medicus (4) 4
adolescent (4) 4
antibodies, monoclonal, murine-derived - therapeutic use (4) 4
antineoplastic agents (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
article (4) 4
biomarkers (4) 4
central nervous system neoplasms - mortality (4) 4
central nervous system neoplasms - therapy (4) 4
combined modality therapy (4) 4
disease (4) 4
disease management (4) 4
elderly (4) 4
fludarabine (4) 4
france (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Future Oncology, ISSN 1479-6694, 09/2015, Volume 11, Issue 18, pp. 2503 - 2513
Obinutuzumab is the second next-generation monoclonal anti-CD20 antibody (after ofatumumab) to enter clinical practice in chronic lymphocytic leukemia. Its... 
Journal Article
Future Oncology, ISSN 1479-6694, 09/2015, Volume 11, Issue 18, pp. 2503 - 2513
Obinutuzumab is the second next-generation monoclonal anti-CD20 antibody (after ofatumumab) to enter clinical practice in chronic lymphocytic leukemia. Its... 
infusion-related reactions | anti-CD20 | minimal residual disease | chronic lymphocytic leukemia | obinutuzumab | PLUS CHLORAMBUCIL | CLL PATIENTS | OPEN-LABEL | B-CELL LYMPHOMA | IN-VITRO | ONCOLOGY | ANTI-CD20 MONOCLONAL-ANTIBODIES | RITUXIMAB | NON-HODGKIN-LYMPHOMA | PHASE-II GAUGUIN | GA101
Journal Article
The Lancet, ISSN 0140-6736, 02/2018, Volume 391, Issue 10121, pp. 659 - 667
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 04/2009, Volume 50, Issue 4, pp. 527 - 533
Journal Article
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 03/2015, Volume 90, Issue 3, pp. 197 - 203
Journal Article
Haematologica, ISSN 0390-6078, 08/2011, Volume 96, Issue 8, pp. 1128 - 1135
Journal Article
Journal Article
Annals of Hematology, ISSN 0939-5555, 5/2016, Volume 95, Issue 6, pp. 1017 - 1018
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00277-016-2646-6 
Medicine & Public Health | Hematology | Oncology | Rhabdomyosarcoma, Alveolar - complications | Diagnosis, Differential | Rhabdomyosarcoma, Alveolar - diagnosis | Bone Marrow - pathology | Humans | Adolescent | Male | Burkitt Lymphoma - diagnosis | Burkitt Lymphoma - complications | Lymphomas
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2016, Volume 34, Issue 30, pp. 3618 - 3626
Purpose Identifying patients at high risk of progression and early death among those with high-tumor-burden follicular lymphoma (FL) is unsatisfactory with... 
FDG-PET | SURVIVAL | IMMUNOCHEMOTHERAPY | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | CYCLOPHOSPHAMIDE | RESPONSE ASSESSMENT | VINCRISTINE | NON-HODGKIN-LYMPHOMA | R-CVP | PROGNOSTIC VALUE | Life Sciences | Cancer
Journal Article